Literature DB >> 32432772

Sevoflurane inhibits neuronal apoptosis and expressions of HIF-1 and HSP70 in brain tissues of rats with cerebral ischemia/reperfusion injury.

F Yu1, L-J Tong, D-S Cai.   

Abstract

OBJECTIVE: To observe the influences of sevoflurane on neuronal apoptosis and expressions of hypoxia-inducible factor 1 (HIF-1), and heat-shock protein 70 (HSP70) in brain tissues of rats with cerebral ischemia/reperfusion (I/R) injury.
MATERIALS AND METHODS: A total of 60 Sprague-Dawley rats were selected and divided into sham-operation group (Sham group, n=20), cerebral I/R model group (Model group, n=20), and 3% sevoflurane treatment group (Sevoflurane group, n=20). The rats in each group received neurological scoring, and the blood and brain tissues were collected to detect the concentrations of serum K+, Na+ and glucose (Glu). Enzyme-linked immunosorbent assay (ELISA) was adopted to measure the levels of inflammatory factors [tumor necrosis factor-β (TNF-β) and interleukin-6 (IL-6)] and oxidative stress [catalase (CAT), malondialdehyde (MDA) and superoxide dismutase (SOD)]. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay was performed to determine the nerve cell apoptosis in the brain tissues. The gene and protein expressions of Caspase-3, HIF-1, and HSP70 in the brain tissues were measured via quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) and Western blotting.
RESULTS: In Sevoflurane group, the content of serum Glu and Na+ was decreased markedly, that of K+ was increased notably, and the levels of TNF-β, IL-1 and IL-6 were lowered remarkably compared with those in Model group (p<0.05). Moreover, the neurological score was reduced evidently (p<0.05). Model group had significantly strengthened the activity of MDA and CAT and decreased SOD content, while Sevoflurane group exhibited the opposite results. TUNEL staining showed that there were distinctly more apoptotic cells that were dominated by glial cells in Model group and fewer apoptotic cells in Sevoflurane group. It was indicated in gene assay that the messenger ribonucleic acid (mRNA) expression levels of HIF-1, HSP70, and Caspase-3 in Model group were remarkably higher than those in Sham group and Sevoflurane group (p<0.05). According to the results of Western blotting, the protein expressions of HIF-1 and HSP70 in Sevoflurane group were markedly lower than those in Model group.
CONCLUSIONS: Sevoflurane can reduce the content of inflammatory factors, inhibit apoptosis, and reduce the expressions of HIF-1 and HSP70 in the case of cerebral I/R injury, thus exerting protective effects on rats with cerebral I/R injury.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32432772     DOI: 10.26355/eurrev_202005_21201

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  Effects of lipoic acid supplementation on age- and iron-induced memory impairment, mitochondrial DNA damage and antioxidant responses.

Authors:  Patrícia Molz; Betânia Souza de Freitas; Vanise Hallas Uberti; Kesiane Mayra da Costa; Luiza Wilges Kist; Maurício Reis Bogo; Nadja Schröder
Journal:  Eur J Nutr       Date:  2021-03-18       Impact factor: 5.614

2.  Sevoflurane alleviates myocardial ischemia/reperfusion injury via actitation of heat shock protein-70 in patients undergoing double valve replacement surgery.

Authors:  Yue Shan; Kai Xie; Qifu Zhou; Rui He; Zhonghua Chen; Weizhong Feng
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

3.  Chlorogenic acid exerts neuroprotective effect against hypoxia-ischemia brain injury in neonatal rats by activating Sirt1 to regulate the Nrf2-NF-κB signaling pathway.

Authors:  Yihui Zheng; Luyao Li; Binwen Chen; Yu Fang; Wei Lin; Tianlei Zhang; Xiaoli Feng; Xiaoyue Tao; Yiqing Wu; Xiaoqin Fu; Zhenlang Lin
Journal:  Cell Commun Signal       Date:  2022-06-10       Impact factor: 7.525

4.  Sevoflurane anesthesia ameliorates LPS-induced acute lung injury (ALI) by modulating a novel LncRNA LINC00839/miR-223/NLRP3 axis.

Authors:  Zhiling Fu; Xiuying Wu; Fushuang Zheng; Yan Zhang
Journal:  BMC Pulm Med       Date:  2022-04-26       Impact factor: 3.320

Review 5.  Hypoxia-Inducible Factor-1: A Potential Target to Treat Acute Lung Injury.

Authors:  Yang Liu; Du Xiang; Hengcheng Zhang; Hanlin Yao; Yanfeng Wang
Journal:  Oxid Med Cell Longev       Date:  2020-11-17       Impact factor: 6.543

6.  Sevoflurane protects against cerebral ischemia/reperfusion injury via microrna-30c-5p modulating homeodomain-interacting protein kinase 1.

Authors:  Guoning Su; Yan Qu; Gang Li; Min Deng
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

7.  Sevoflurane pretreatment regulates abnormal expression of MicroRNAs associated with spinal cord ischemia/reperfusion injury in rats.

Authors:  Dan Wang; Bo Fang; Zhilin Wang; Xiaoqian Li; Fengshou Chen
Journal:  Ann Transl Med       Date:  2021-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.